Recommendations for cyclin-dependent kinase 4/6 inhibitor treatments in the context of co-morbidity and drug interactions (Review)

Teomete, Mehmet; Cabuk, Devrim; Korkmaz, Taner; Seber, Selcuk; Ozturk, Ozge Fulya; Aver, Birkan; Karaalp, Atila; Basaran, Gul

doi:10.3892/ol.2024.14278

Recommendations for cyclin-dependent kinase 4/6 inhibitor treatments in the context of co-morbidity and drug interactions (Review)

Date

2024

Authors

dc.identifier.doi

10.3892/ol.2024.14278

dc.identifier.other

WOS:001169395400001

Publisher

SPANDIDOS PUBL LTD

DOI

10.3892/ol.2024.14278

Keywords

advanced breast cancer , comorbidity , cyclin\\-dependent kinase 4 and 6 inhibitors , safety , tolerability , toxicity

URI

https://openaccess.acibadem.edu.tr/handle/11443/5875

Collections

WOS

Full item page

Recommendations for cyclin-dependent kinase 4/6 inhibitor treatments in the context of co-morbidity and drug interactions (Review)

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By